120 related articles for article (PubMed ID: 38417136)
1. β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma.
Wang Y; Cheng C; Lu Y; Lian Z; Liu Q; Xu Y; Li Y; Li H; Zhang L; Jiang X; Li B; Yu D
Cancer Res; 2024 May; 84(10):1643-1658. PubMed ID: 38417136
[TBL] [Abstract][Full Text] [Related]
2. Phospholipid isotope tracing suggests β-catenin-driven suppression of phosphatidylcholine metabolism in hepatocellular carcinoma.
VanSant-Webb C; Low HK; Kuramoto J; Stanley CE; Qiang H; Su AY; Ross AN; Cooper CG; Cox JE; Summers SA; Evason KJ; Ducker GS
Biochim Biophys Acta Mol Cell Biol Lipids; 2024 Aug; 1869(6):159514. PubMed ID: 38795827
[TBL] [Abstract][Full Text] [Related]
3. CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer.
Liu Y; Wang F; Yan G; Tong Y; Guo W; Li S; Qian Y; Li Q; Shu Y; Zhang L; Zhang Y; Xia Q
Cancer Lett; 2024 Jul; 595():217006. PubMed ID: 38823763
[TBL] [Abstract][Full Text] [Related]
4. Research progress in the metabolic reprogramming of hepatocellular carcinoma (Review).
Gao W; Wang J; Xu Y; Yu H; Yi S; Bai C; Cong Q; Zhu Y
Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38818815
[TBL] [Abstract][Full Text] [Related]
5. Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass.
Spinelli JB; Yoon H; Ringel AE; Jeanfavre S; Clish CB; Haigis MC
Science; 2017 Nov; 358(6365):941-946. PubMed ID: 29025995
[TBL] [Abstract][Full Text] [Related]
6. Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma.
Liu R; Li Y; Tian L; Shi H; Wang J; Liang Y; Sun B; Wang S; Zhou M; Wu L; Nie J; Lin B; Tang S; Zhang Y; Wang G; Zhang C; Han J; Xu B; Liu L; Gong K; Zheng T
Cancer Lett; 2019 Feb; 443():34-46. PubMed ID: 30503555
[TBL] [Abstract][Full Text] [Related]
7. The switch triggering the invasion process: Lipid metabolism in the metastasis of hepatocellular carcinoma.
Zhang J; Zhang Z; Wu Z; Wang Y; Zhang Z; Xia L
Chin Med J (Engl); 2024 Jun; 137(11):1271-1284. PubMed ID: 38738689
[TBL] [Abstract][Full Text] [Related]
8. Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.
Latasa MU; Salis F; Urtasun R; Garcia-Irigoyen O; Elizalde M; Uriarte I; Santamaria M; Feo F; Pascale RM; Prieto J; Berasain C; Avila MA
PLoS One; 2012; 7(12):e52711. PubMed ID: 23285165
[TBL] [Abstract][Full Text] [Related]
9. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
[TBL] [Abstract][Full Text] [Related]
10. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
Li H; Lan T; Xu L; Liu H; Wang J; Li J; Chen X; Huang J; Li X; Yuan K; Zeng Y; Wu H
J Exp Clin Cancer Res; 2020 Jul; 39(1):128. PubMed ID: 32631394
[TBL] [Abstract][Full Text] [Related]
11. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
12. The Protein Kinase Activity of NME7 Activates Wnt/β-Catenin Signaling to Promote One-Carbon Metabolism in Hepatocellular Carcinoma.
Ren X; Rong Z; Liu X; Gao J; Xu X; Zi Y; Mu Y; Guan Y; Cao Z; Zhang Y; Zeng Z; Fan Q; Wang X; Pei Q; Wang X; Xin H; Li Z; Nie Y; Qiu Z; Li N; Sun L; Deng Y
Cancer Res; 2022 Jan; 82(1):60-74. PubMed ID: 34764205
[TBL] [Abstract][Full Text] [Related]
13. Phospholipid isotope tracing reveals β-catenin-driven suppression of phosphatidylcholine metabolism in hepatocellular carcinoma.
VanSant-Webb C; Low HK; Kuramoto J; Stanley CE; Qiang H; Su A; Ross AN; Cooper CG; Cox JE; Summers SA; Evason KJ; Ducker GS
bioRxiv; 2023 Oct; ():. PubMed ID: 37904922
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of cuproptosis‑related gene LIPT1 is associated with metabolic dysregulation of fatty acid and prognosis in hepatocellular carcinoma.
Li J; Tuo D; Guo G; Gan J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15763-15779. PubMed ID: 37668796
[TBL] [Abstract][Full Text] [Related]
15. Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.
Tan HY; Wang N; Li S; Hong M; Guo W; Man K; Cheng CS; Chen Z; Feng Y
Cell Physiol Biochem; 2018; 47(5):1819-1834. PubMed ID: 29953980
[TBL] [Abstract][Full Text] [Related]
16. DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway.
Zhang T; Ma Z; Liu L; Sun J; Tang H; Zhang B; Zou Y; Li H
Cell Death Dis; 2018 Jun; 9(6):675. PubMed ID: 29867138
[TBL] [Abstract][Full Text] [Related]
17. Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation.
Hung MH; Chen YL; Chen LJ; Chu PY; Hsieh FS; Tsai MH; Shih CT; Chao TI; Huang CY; Chen KF
Cell Death Dis; 2019 May; 10(6):420. PubMed ID: 31142735
[TBL] [Abstract][Full Text] [Related]
18. Cyr61/CCN1 is regulated by Wnt/β-catenin signaling and plays an important role in the progression of hepatocellular carcinoma.
Li ZQ; Ding W; Sun SJ; Li J; Pan J; Zhao C; Wu WR; Si WK
PLoS One; 2012; 7(4):e35754. PubMed ID: 22540002
[TBL] [Abstract][Full Text] [Related]
19. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M
J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133
[TBL] [Abstract][Full Text] [Related]
20. SOX10 is a novel oncogene in hepatocellular carcinoma through Wnt/β-catenin/TCF4 cascade.
Zhou D; Bai F; Zhang X; Hu M; Zhao G; Zhao Z; Liu R
Tumour Biol; 2014 Oct; 35(10):9935-40. PubMed ID: 25001176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
